GAIN THERAPEUTICS, INC Capitalized Computer Software, Net
GAIN THERAPEUTICS, INC (GANX) had Capitalized Computer Software, Net of $76.78 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:CapitalizedComputerSoftwareNet · last filed 2026-08-11
- 2026-06-30: Capitalized Computer Software, Net $76.78K.
- 2026-03-31: Capitalized Computer Software, Net $90.05K.
- 2025-12-31: Capitalized Computer Software, Net $102.84K.
- 2025-09-30: Capitalized Computer Software, Net $114.61K.
| Period end | Capitalized Computer Software, Net |
|---|---|
| 2026-06-30 | $76.78K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $90.05K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $102.84K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $114.61K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $127.86K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $126.29K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $134.27K 10-K · filed 2026-03-26 |
| 2024-09-30 | $156.26K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $158.15K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $169.25K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $193.38K 10-K · filed 2025-03-27 |
| 2023-09-30 | $189.24K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $204.55K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $208.91K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $213.97K 10-K · filed 2024-03-26 |
| 2022-09-30 | $208.33K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $207.67K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $202.51K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $202.61K 10-K · filed 2023-03-23 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |